Effect of 30-minutes versus 60-minutes uterine artery occlusion tourniquet time during open myomectomy on levels of anti-mullerian hormone: a randomized clinical study in NAUTH, Nnewi, Nigeria.
Not Applicable
Recruiting
- Conditions
- Fertility-female
- Registration Number
- PACTR202307527164991
- Lead Sponsor
- Dr Lambert Chukwu Onyejiaku
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 96
Inclusion Criteria
1.?Symptomatic women with uterine fibroids who wish to preserve their uterus
2.?Age between 20 to 45 years
3. women with regular menstruation.
Exclusion Criteria
1.?Women less than 20 or over 45 years of age
2.?Use of Gonadotropin releasing hormone agonists or oral contraceptive in the past 3 months prior to recruitment.
3. History of use of phytoestrogen or herbal medication in the previous 3 months before recruitment
4. Women with clinical features of ovarian insufficiency
5.?Patients who were identified with any disease other than myoma (polycystic ovarian syndrome, endometriosis, tumor, etc.) during surgery
6. Association with adnexal tumors or previous adnexal surgery at the same time
7.?Positive pregnancy test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure is mean difference in serum AMH before and after tourniquet application.
- Secondary Outcome Measures
Name Time Method The secondary outcome measure is mean serum AMH levels for different durations of tourniquet occlusion time.